Related Experiment Video

Updated: Aug 16, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta

F Jaffer1, C Saunders, P Shultz

  • 1Department of Medicine, VA Medical Center, Cleveland, Ohio 44106.

The American Journal of Pathology
|August 1, 1989
PubMed

Insights

Transforming growth factor beta (TGF-beta) inhibits human mesangial cell growth and DNA synthesis, unlike other peptide growth factors. Further research is needed to determine the exact mechanism behind TGF-beta

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Mesangial cell proliferation is a hallmark of glomerular diseases.
  • Platelets and macrophages are implicated in mediating glomerular hypercellularity.
  • Previous research identified peptide growth factors that stimulate mesangial cell DNA synthesis.

Purpose of the Study:

  • To investigate the effect of transforming growth factor beta (TGF-beta) on human mesangial cell DNA synthesis and growth.
  • To explore the mechanism of TGF-beta's action, including its interaction with growth factor receptors and mRNA expression.

Main Methods:

  • Human mesangial cells were treated with TGF-beta, epidermal growth factor (EGF), and platelet-derived growth factor (PDGF).
  • DNA synthesis was assessed using autoradiography.
  • Cell proliferation was quantified by cell counting.
  • The effect of TGF-beta on growth factor binding and PDGF mRNA levels was analyzed.

Main Results:

  • TGF-beta significantly inhibited DNA synthesis and growth of human mesangial cells.
  • This inhibitory effect was not due to interference with EGF or PDGF receptor binding.
  • TGF-beta did not reduce the elevated PDGF mRNA levels induced by EGF or PDGF.

Conclusions:

  • TGF-beta acts as a potent inhibitor of human mesangial cell proliferation and DNA synthesis.
  • The inhibitory mechanism of TGF-beta in mesangial cells requires further elucidation.
  • These findings contribute to understanding the complex regulation of glomerular cell growth in kidney diseases.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...